221 related articles for article (PubMed ID: 27093633)
1. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
[TBL] [Abstract][Full Text] [Related]
2. Range of Effective Corticosteroid Doses for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):10-15. PubMed ID: 28287356
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Corticosteroid Monotherapy for Dyspnea Relief in Patients with Terminal Cancer.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2017 Jun; 31(2):148-153. PubMed ID: 28358257
[TBL] [Abstract][Full Text] [Related]
4. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
[TBL] [Abstract][Full Text] [Related]
5. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
[TBL] [Abstract][Full Text] [Related]
6. Opioids for Relief of Dyspnea Immediately Before Death in Patients With Noncancer Disease: A Case Series Study.
Murakami M
Am J Hosp Palliat Care; 2019 Aug; 36(8):734-739. PubMed ID: 30803242
[TBL] [Abstract][Full Text] [Related]
7. A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids.
Uekuzu Y; Higashiguchi T; Futamura A; Ito A; Mori N; Murai M; Ohara H; Awa H; Chihara T
Biol Pharm Bull; 2017 Mar; 40(3):278-283. PubMed ID: 27980244
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of opioid switching for dyspnea and its predictors in cancer patients: a single-center retrospective observational study.
Yamamoto Y; Tanaka S; Matsuura K; Yamamoto S; Urano K; Okita J; Kato E; Odagiri T; Deguchi Y
Jpn J Clin Oncol; 2024 May; 54(5):549-555. PubMed ID: 38323655
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
[TBL] [Abstract][Full Text] [Related]
12. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
[TBL] [Abstract][Full Text] [Related]
13. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer.
Pinna MÁ; Bruera E; Moralo MJ; Correas MÁ; Vargas RM
Am J Hosp Palliat Care; 2015 May; 32(3):298-304. PubMed ID: 24259406
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea.
Pang GS; Qu LM; Tan YY; Yee AC
Am J Hosp Palliat Care; 2016 Apr; 33(3):222-7. PubMed ID: 25425740
[TBL] [Abstract][Full Text] [Related]
15. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
16. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
17. Effect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspnea.
Yamamoto Y; Watanabe H; Sakurai A; Deguchi Y; Hirano S; Okumura Y; Kumon A; Watanabe N; Osada T; Yamamura K; Odagiri T
Jpn J Clin Oncol; 2018 Aug; 48(8):748-752. PubMed ID: 29893883
[TBL] [Abstract][Full Text] [Related]
18. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
19. Opioid use in end-of-life care in patients with interstitial pneumonia associated with respiratory worsening.
Tsukuura H; Nishimura K; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Watanabe N; Hasegawa Y
J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):214-9. PubMed ID: 24004314
[TBL] [Abstract][Full Text] [Related]
20. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review.
Vargas-Bermúdez A; Cardenal F; Porta-Sales J
J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
